[{"AccountsPayableCurrent_0_Q2_USD":26605000.0,"EarningsPerShareDiluted_2_Q2_USD":-0.72,"NetIncomeLossAvailableToCommonStockholdersDiluted_1_Q2_USD":-77740000.0,"NetIncomeLossAvailableToCommonStockholdersDiluted_2_Q2_USD":-142935000.0,"TreasuryStockShares_0_Q2_shares":7568182.0,"TreasuryStockValue_0_Q2_USD":49464000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q2_USD":-85003000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_2_Q2_USD":-154128000.0,"IncomeLossFromEquityMethodInvestments_1_Q2_USD":-4699000.0,"EarningsPerShareDiluted_1_Q2_USD":-0.36,"IncomeLossFromEquityMethodInvestments_2_Q2_USD":-5255000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":69388000.0,"IncreaseDecreaseInContractWithCustomerLiability_2_Q2_USD":-144000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_2_Q2_USD":45000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q2_USD":-10000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q2_USD":61324000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":17909000.0,"StockGrantedDuringPeriodValueSharebasedCompensationGross_1_Q2_USD":3335000.0,"StockGrantedDuringPeriodValueSharebasedCompensationGross_2_Q2_USD":7017000.0,"ProceedsFromShortTermDebt_2_Q2_USD":7815000.0,"DerivativeLiabilitiesNoncurrent_0_Q2_USD":41900000.0,"RepaymentsOfLongTermDebt_2_Q2_USD":131853000.0,"LongTermDebtCurrent_0_Q2_USD":19151000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":216956000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":199782000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":989702000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q2_USD":9007000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_2_Q2_USD":16728000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-77750000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-142890000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q2_USD":-7253000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":42757000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_2_Q2_USD":-11238000.0,"OperatingLeaseExpense_2_Q2_USD":5072000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-10000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":45000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q2_USD":-82213000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_2_Q2_USD":-151113000.0,"DeferredIncomeTaxesAndTaxCredits_2_Q2_USD":-1989000.0,"InvestmentIncomeInterest_1_Q2_USD":2000.0,"InvestmentIncomeInterest_2_Q2_USD":21000.0,"OperatingLeaseExpense_1_Q2_USD":2533000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":151813000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":549000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q2_USD":124000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":4993000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":42670000.0,"NumberOfOperatingSegments_2_Q2_segment":2.0,"NumberOfReportableSegments_2_Q2_segment":2.0,"OperatingLeaseLiability_0_Q2_USD":54660000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":3460000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":51200000.0,"OperatingLeasePayments_1_Q2_USD":2487000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":9710000.0,"OperatingLeasePayments_2_Q2_USD":4896000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.122,"PaidInKindInterest_2_Q2_USD":7955000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_2_Q2_USD":2312000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":24150000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":45304000.0,"ResearchAndDevelopmentInProcess_1_Q2_USD":4881000.0,"ResearchAndDevelopmentInProcess_2_Q2_USD":4881000.0,"RestrictedCash_0_Q2_USD":45000000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":45070000.0,"EquityMethodInvestments_0_Q2_USD":19978000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":9764000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q2_USD":10117000.0,"ForeignCurrencyTransactionGainLossBeforeTax_2_Q2_USD":-23000.0,"IncreaseDecreaseInEmployeeRelatedLiabilities_2_Q2_USD":1995000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q2_USD":398000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":69388000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":-11395000.0,"ContractWithCustomerLiabilityCurrent_0_Q2_USD":4107000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q2_USD":113781000.0,"DebtSecuritiesTradingRealizedGainLoss_2_Q2_USD":-59000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":9993000.0,"DerivativeGainLossOnDerivativeNet_1_Q2_USD":1980000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2_Q2_USD":14000.0,"EquitySecuritiesFvNiGainLoss_1_Q2_USD":3800000.0,"EquitySecuritiesFvNiGainLoss_2_Q2_USD":3800000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q2_USD":1984000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_2_Q2_USD":73000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q2_USD":14400000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q2_USD":74620000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":97330000.0,"DerivativeGainLossOnDerivativeNet_2_Q2_USD":6900000.0,"RestrictedCashNoncurrent_0_Q2_USD":45000000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":81533000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":34748000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-76075000.0,"NetIncomeLoss_1_Q2_USD":-77740000.0,"NetIncomeLoss_2_Q2_USD":-142935000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":970000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":14365000.0,"ProfitLoss_1_Q2_USD":-84993000.0,"ProfitLoss_2_Q2_USD":-154173000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":27523000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-3282000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-802753000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":19711000.0,"AdjustmentForAmortization_1_Q2_USD":992000.0,"AdjustmentForAmortization_2_Q2_USD":1984000.0,"CommitmentsAndContingencies_0_Q2_USD":null,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"CommonStockSharesAuthorized_0_Q2_shares":750000000.0,"DepreciationAndAmortization_2_Q2_USD":5653000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_2_Q2_pure":0.21,"StockholdersEquity_0_Q2_USD":137285000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":13296000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":67962000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":533068000.0,"AccountsReceivableNetCurrent_0_Q2_USD":13801000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-225000.0,"Assets_0_Q2_USD":533068000.0,"AssetsCurrent_0_Q2_USD":55001000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":24388000.0,"CommonStockSharesIssued_0_Q2_shares":231846901.0,"CommonStockSharesOutstanding_0_Q2_shares":231846901.0,"CommonStockValue_0_Q2_USD":25000.0,"LiabilitiesCurrent_0_Q2_USD":91341000.0,"CostsAndExpenses_2_Q2_USD":107619000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":24463000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":50762000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-1919000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":-2195000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":-1241000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-1612000.0,"InventoryNet_0_Q2_USD":2447000.0,"Liabilities_0_Q2_USD":452853000.0,"CostsAndExpenses_1_Q2_USD":56735000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.23,"InterestExpense_1_Q2_USD":8297000.0,"InterestPaidNet_2_Q2_USD":3148000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.17,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":4.69,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q2_USD":80215000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":217000.0,"EarningsPerShareBasic_2_Q2_USD":-0.72,"EarningsPerShareBasic_1_Q2_USD":-0.36,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_0_Q2_USD":3870000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q2_USD":3961000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":4.5,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q2_USD":3966000.0,"Goodwill_0_Q2_USD":38298000.0,"LongTermDebtNoncurrent_0_Q2_USD":147027000.0,"MinorityInterest_0_Q2_USD":-57070000.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q2_USD":-7253000.0,"NetIncomeLossAttributableToNoncontrollingInterest_2_Q2_USD":-11238000.0,"OtherAssetsNoncurrent_0_Q2_USD":3866000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_2_Q2_shares":2163493.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":5359500.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q2_USD":3966000.0,"InterestExpense_2_Q2_USD":15122000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":16856723.0,"GainsLossesOnExtinguishmentOfDebt_1_Q2_USD":-28294000.0,"OperatingIncomeLoss_2_Q2_USD":-90891000.0,"OperatingIncomeLoss_1_Q2_USD":-47728000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockSharesAuthorized_0_Q2_shares":100000000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"PreferredStockValue_0_Q2_USD":null,"ShareBasedCompensation_2_Q2_USD":7017000.0,"FiniteLivedIntangibleAssetsNet_0_Q2_USD":46965000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":925945.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":3797000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":216956000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":199782000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q2_USD":7055000.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.015,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.023,"IncreaseDecreaseInReceivables_2_Q2_USD":-655000.0,"GainsLossesOnExtinguishmentOfDebt_2_Q2_USD":-51939000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":3896000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_2_Q2_USD":795000.0,"Ticker":"SRNE","CIK":"850261","name":"SORRENTO THERAPEUTICS, INC.","OfficialName":"Sorrento Therapeutics Inc.  Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"636044097.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Commercial Physical & Biological Resarch","Market":"NASDAQ","SP500":"nan","filed":"20200804"}]